Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
2013 · The Lancet · 352 citations
https://doi.org/10.1016/s0140-6736(13)60023-9
B
Brian N. Bundy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
166
Papers
33.6K
Citations
67
h-index
99
i10-index
Brian N. Bundy is an academic researcher from University of South Florida. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Ovarian cancer diagnosis and treatment & Diabetes and associated disorders. The author has an h-index of 67, co-authored 142 publications.
ORCID: 0000-0003-3478-714XPapers by this author
worksA Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
2018 · Diabetes Care · 165 citations
https://doi.org/10.2337/dc18-0087
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
2018 · Diabetes Care · 165 citations
https://doi.org/10.2337/dc18-0087
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
2021 · The Lancet Diabetes & Endocrinology · 123 citations
https://doi.org/10.1016/s2213-8587(21)00139-x
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
2021 · The Lancet Diabetes & Endocrinology · 123 citations
https://doi.org/10.1016/s2213-8587(21)00139-x
Episodic Ataxia Type 1: Natural History and Effect on Quality of Life
2022 · The Cerebellum · 1 citations
https://doi.org/10.1007/s12311-021-01360-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat